Skip to content

Total debt at other companies

LivaNova logo
LivaNovaLIVN
$340.94M-49.7%
ICU Medical logo
ICU MedicalICUI
$1.36B-17.5%
OSI Systems logo
OSI SystemsOSIS
$1.05B+107%
Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s total debt?
TransMedics Group, Inc. (TMDX) reported total debt of $409.89M in Q1 2026.
How has TransMedics Group, Inc.'s total debt changed year-over-year?
TransMedics Group, Inc.'s total debt increased by 504.9% year-over-year, from $67.76M to $409.89M.
What is the long-term trend for TransMedics Group, Inc.'s total debt?
Over 5 years (2020 to 2025), TransMedics Group, Inc.'s total debt has grown at a 13.9% compound annual growth rate (CAGR), from $34.66M to $66.47M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.